In patients with IgA deficiency, IgG-based serological testing for tTG (anti-tTG IgG), deamidated gliadin peptide (DGP IgG), or anti-endomysial antibodies IgG (EMA-IgG) should be performed [41,43,45]. Here, TGM2 is linked to selective IgA deficiency disease.